Key facts
- Notable investors include Excedea Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Apomed
- ·The full record, as it builds
Funding rounds
No funding rounds for Apomed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Apomed
Operator of an online pharmacy service intended to provide convenient and accessible healthcare products to customers. The company offers a range of pharmacy products and expert advice and delivers directly to customers' homes, enabling customers to manage their healthcare needs efficiently and securely.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Oslo, Norway
- Founded
- 2023
- Employees
- 4
- Website
- apomed.no/
- Ownership
- Privately Held (backing)
Apomed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Apomed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Apomed in its N-PORT filings yet. We sweep new filings monthly.